+ data and comments+, page-2

1. CHEMEQ(R)(TM) polymeric antimicrobial is an alternative to the use of human antibiotics in animals.

FAQ's: http://www.chemeq.com.au/faq.html

Extract: "Chemeq Ltd is on-track to produce commercial-scale quantities of CHEMEQ® polymeric antimicrobials from its new manufacturing facilities, towards the end of 2003.

The initial output will be exported to South Africa and New Zealand where Chemeq has received regulatory approval - with Asia, Australia and other international markets to follow".

"CHEMEQ(RTM) polymeric antimicrobial is an alternative to the use of human antibiotics in animals. Excessive use of human antibiotics in animals produces antibiotic-resistant germs, which find their way back to humans through the animal-food chain. Antibiotic resistance is already a major problem in hospitals around the world". (Superbugs):
http://www.fda.gov/fdac/features/1998/698_bugs.html

Mc Donald's Corporation is asking suppliers to phase out growth promoting antibiotics:
http://stocknessmonster.com/news-item?S=CMQ&E=ASX&N=239249


Independent trial: Chickens:
http://stocknessmonster.com/news-item?S=CMQ&E=ASX&N=222797

Presentation in South Africa:
http://stocknessmonster.com/news-item?S=CMQ&E=ASX&N=222408

From CMQ, date Oct. 2001: " With ERS, full FDA approval would take 2-3 years. Without ERS, approval
would take 5-6 years".

Latest on ERS and FDA approval (Halcyon=Gerry Stolwyk):
http://www.ozestock.com.au/MessageView.asp?PostID=250889&Symbol=CMQ

Gerry
CMQ: http://www.chemeq.com.au/company_intro.html